Eric Thomason
Psychiatric/Mental Health · Pittsburg, KSNPI 1528425501
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $241,074 of the $333,405 with a category attached, or 72.3%. Otsuka America Pharmaceutical, Inc. accounts for 66.7% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $115,077, more than ten times the $69 reported in 2021. Among psychiatric/mental health clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 766 payments — averaging $435.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$222K
- AbbVie$60K
- E.r. Squibb & Sons, L.L.C.$40K
- Alkermes, Inc.$5K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$4K
- Lundbeck LLC$293
- plus $758 from 10 others
What the payments were for
- Consulting fees$41,12812%
- Speaking & faculty fees$241,07472%
- Travel & lodging$40,30812%
- Food & beverage$10,8683%
- Education$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 494 | $222,232 |
| AbbVie | 131 | $60,335 |
| E.r. Squibb & Sons, L.L.C. | 81 | $40,344 |
| Alkermes, Inc. | 25 | $5,227 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $4,216 |
| Lundbeck LLC | 3 | $293 |
| Axsome Therapeutics, Inc. | 9 | $187 |
| Teva Pharmaceuticals USA, Inc. | 5 | $148 |
| Novo Nordisk | 1 | $125 |
| Dexcom, Inc. | 1 | $123 |
| Sunovion Pharmaceuticals Inc. | 6 | $72 |
| Johnson & Johnson | 2 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Corium, LLC | 1 | $16 |
| Braeburn Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$116,900
- ABILIFY MAINTENA$87,972
- ABILIFY ASIMTUFII$83,524
- VRAYLAR$58,431
- COBENFY$26,693
- LYBALVI$14,167
- ARISTADA$6,596
- ABILIFY MYCITE$4,141
- Wegovy$125
- Austedo XR$123
- DEXCOM G7 GSS (161)$123
- DEXCOM STELO GLUCOSE BIOSENSOR$123
- Auvelity$117
How this compares
$333,405 in reported general payments places this provider in the 95th percentile of 404 psychiatric/mental health providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $94,795 |
| VraylarCariprazine Hcl | 41 | $56,524 |
| RexultiBrexpiprazole | 18 | $21,713 |
| BelsomraSuvorexant | 11 | $4,667 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 15 | $1,255 |
| Buspirone Hcl | 68 | $858 |
| Quetiapine Fumarate | 26 | $769 |
| Duloxetine Hcl | 26 | $687 |
| Oxcarbazepine | 11 | $564 |
| Gabapentin | 40 | $506 |
| Aripiprazole | 26 | $486 |
| Sertraline Hcl | 59 | $461 |
| Mirtazapine | 13 | $308 |
| Prazosin Hcl | 12 | $305 |
| LoxapineLoxapine Succinate | 12 | $292 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $60,335 | $56,52441 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $222,232 | $21,71318 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $148 | $29212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 404 psychiatric/mental health providers in Kansas.
Other psychiatric/mental health in Pittsburg
- Uyen DinhPittsburg$20K
- Melissa JohnstonPittsburg$6K
- Belinda BagbyHutchinson$39K
- Hayley KnappWichita$31K
- Jennifer KubinBaldwin City$26K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
- Deborah MurphyWichita$13K
- Marijen AgaShawnee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.